Resultats de la cerca - Anat Stemmer‐Rachamimov
- Mostrar 1 - 20 resultats de 77
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
-
7
YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2–EGFR Signaling Axis per William Guerrant, Smitha Kota, Scott Troutman, Vinay Mandati, Mohammad Fallahi, Anat Stemmer‐Rachamimov, Joseph L. Kissil
Publicat 2016Artigo -
8
-
9
-
10
-
11
Perinatal or Adult <i>Nf1</i> Inactivation Using Tamoxifen-Inducible <i>PlpCre</i> Each Cause Neurofibroma Formation per Debra A. Mayes, Tilat A. Rizvi, José A. Cancelas, Nathan T. Kolasinski, Georgianne M. Ciraolo, Anat Stemmer‐Rachamimov, Nancy Ratner
Publicat 2011Artigo -
12
-
13
NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth per Marianne F. James, Sangyeul Han, Carolyn Polizzano, Scott R. Plotkin, Brendan D. Manning, Anat Stemmer‐Rachamimov, James F. Gusella, Vijaya Ramesh
Publicat 2009Artigo -
14
Immunohistochemical Analysis Supports a Role for INI1/SMARCB1 in Hereditary Forms of Schwannomas, but Not in Solitary, Sporadic Schwannomas per Sushama Patil, Arie Perry, Mia MacCollin, Shumin Dong, Rebecca A. Betensky, Tu‐Hsueh Yeh, David H. Gutmann, Anat Stemmer‐Rachamimov
Publicat 2008Artigo -
15
Breast Cancer‐Derived Extracellular Vesicles Modulate the Cytoplasmic and Cytoskeletal Dynamics of Blood‐Brain Barrier Endothelial Cells per Sara Busatto, Tzu‐Hsi Song, Hyung Joon Kim, Caleb Hallinan, Michael N. Lombardo, Anat Stemmer‐Rachamimov, Kwonmoo Lee, Marsha A. Moses
Publicat 2025Artigo -
16
Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma per Shumin Dong, Catherine L. Nutt, Rebecca A. Betensky, Anat Stemmer‐Rachamimov, Nicholas Denko, Keith L. Ligon, David H. Rowitch, David N. Louis
Publicat 2005Artigo -
17
Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma per Wei Zhang, Giulia Fulci, Jason S. Buhrman, Anat Stemmer‐Rachamimov, John W. Chen, Gregory R. Wojtkiewicz, Ralph Weissleder, Samuel D. Rabkin, Robert L. Martuza
Publicat 2011Artigo -
18
Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2–Deficient Target Cell Types per Marianne F. James, Elizabeth Stivison, Roberta L. Beauchamp, Sangyeul Han, Hua Li, Margaret R. Wallace, James F. Gusella, Anat Stemmer‐Rachamimov, Vijaya Ramesh
Publicat 2012Artigo -
19
Plexiform and Dermal Neurofibromas and Pigmentation Are Caused by Nf1 Loss in Desert Hedgehog-Expressing Cells per Jianqiang Wu, Jon Williams, Tilat A. Rizvi, Jennifer J. Kordich, David P. Witte, Dies Meijer, Anat Stemmer‐Rachamimov, José A. Cancelas, Nancy Ratner
Publicat 2008Artigo -
20
Insights into Meningioangiomatosis with and without Meningioma: A Clinicopathologic and Genetic Series of 24 Cases with Review of the Literature per Arie Perry, Özlem Kurtkaya-Yapıcıer, Bernd W. Scheithauer, Shenandoah Robinson, Richard A. Prayson, Bette K. Kleinschmidt‐DeMasters, Anat Stemmer‐Rachamimov, David H. Gutmann
Publicat 2006Artigo
Eines de cerca:
Matèries relacionades
Biology
Medicine
Cancer research
Pathology
Genetics
Gene
Neurofibromatosis
Cell biology
Internal medicine
Cancer
Neurofibromatosis type 2
Carcinogenesis
Signal transduction
Biochemistry
Immunology
Meningioma
Mutation
Suppressor
Oncology
Glioma
Merlin (protein)
Neuroscience
Immunohistochemistry
Receptor
Chemotherapy
Gene expression
Neurofibroma
Schwannoma
Bevacizumab
Cell